Other surrogate biomarkers for NAFLD, including liver enzymes (ALT, AST, and GGT) and fibrotic markers (TGF-β1, TIMP-1), were not elevated in our NAFLD-HIL mouse model. The gene discussed is TIMP1; the disease is metabolic dysfunction-associated steatotic liver disease.